Drug-Eluting Stents Market Report by Coating (Polymer Based Coating, Polymer Free Coating), Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), Stent Platform (Stainless-steel, Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), Generation (1st Generation, 2nd Generation, 3rd Generation, 4th Generation), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region ?2026-2034?
The global drug-eluting stents market size reached USD 9.2 Billion in 2025. Looking forward, the market is expected to reach USD 14.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.03% during 2026-2034. The increasing prevalence of cardiovascular diseases is propelling the market.
DRUG-ELUTING STENTS MARKET ANALYSIS:
Implementation of Next-Generation Drugs
The next generation of drug-eluting stents uses advanced medications, such as biolimus and zotarolimus, which have higher efficacy in preventing restenosis while reducing adverse effects, making these stents more useful for a wider variety of patients. For example, in May 2024, Abbott announced the launch of XIENCE Sierra Everolimus (drug) eluting coronary stent system in India. It is a CE-marked and one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. This is leading to the drug-eluting stents market growth.
Expanded Use in Peripheral Artery Disease
Drug-eluting stents are being increasingly utilized to treat peripheral arterial disease (PAD), moving beyond coronary applications. This trend reflects stents' growing use in treating blockages in arteries beyond the heart. In April 2024, Cook Medical received a contract to supply implantable devices to hospitals run by the U.S. Department of Defense (DoD). The company would provide its Zilver PTX drug-eluting peripheral stent, Zenith aortic endograft, and other implantable devices. This is expanding the drug-eluting stents market share.
Increasing Focus on Complex Lesions
Drug-eluting stents are in high demand for treating complicated coronary lesions such as bifurcation and multi-vessel disease. These advanced stents are designed to handle complex anatomical issues with more precision. In June 2024, Elixir Medical's DynamX Sirolimus-Eluting Coronary Bioadaptor System received Breakthrough Device Designation from the FDA. This bioadaptive implant aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease.
GLOBAL DRUG-ELUTING STENTS INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the drug-eluting stents market forecast at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on the coating, drug, stent platform, generation, application, and end user.
Breakup by Coating:
The report has provided a detailed breakup and analysis of the market based on the coating. This includes polymer based coating and polymer free coating. According to the report, polymer free coating represented the largest market segmentation.
Polymer free coating is intended to minimize inflammation and promote healing. These coatings improve medication delivery while eliminating the problems associated with polymers, resulting in better patient outcomes during cardiovascular treatments. This is elevating the drug-eluting stents market revenue.
Breakup by Drug:
The drug-eluting stents market overview highlights that sirolimus reduces cell development to avoid arterial narrowing, while paclitaxel inhibits cell division, resulting in better blood flow. Zotarolimus enhances healing while causing less adverse effects, and everolimus has been shown to reduce re-narrowing over time. Biolimus, a biodegradable alternative, promotes vascular recovery, providing a variety of therapy options in the market.
Breakup by Stent Platform:
The report has provided a detailed breakup and analysis of the market based on the stent platform. This includes stainless-steel, cobalt-chromium, platinum-chromium, nitinol, and others. According to the report, cobalt-chromium represented the largest market segmentation.
Cobalt-chromium stents are well-known for their long-lasting, flexible, and biocompatible design. These stents have a sturdy construction but allow for thinner struts, which improves vessel support and reduces problems during cardiovascular treatments. This is elevating the drug-eluting stents market statistics.
Breakup by Generation:
The 1st generation drug-eluting stents used basic drug coatings to minimize restenosis. The 2nd generation increased safety by improving biocompatibility and using thinner struts. The 3rd generation focused on biodegradable polymers to improve healing, while the 4th generation uses polymer-free coatings to promote speedier recovery and reduce inflammation. Each generation represents advances in safety, efficacy, and patient outcomes.
Breakup by Application:
The report has provided a detailed breakup and analysis of the market based on the application. This includes coronary artery disease and peripheral artery disease. According to the report, coronary artery disease represented the largest market segmentation.
The market largely focuses on coronary artery disease by releasing medications that prevent restenosis. These stents help to maintain artery patency, improve blood flow, and reduce the need for repeat treatments in patients with blocked or narrowed arteries.
Breakup by End User:
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest market segmentation.
Hospitals are the primary end users in this market, as these devices are commonly utilized in cardiovascular surgeries to treat coronary artery disease. These stents are used in hospitals to improve patient outcomes, lower restenosis, and reduce the need for recurrent treatments. This represents one of the drug-eluting stents market recent opportunities.
Breakup by Region:
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America exhibits a clear dominance in the market. This can be attributed to the enhanced healthcare infrastructure, a high prevalence of cardiovascular illnesses, and the growing adoption of cutting-edge stent technology. The region's focus on reducing coronary artery disease promotes demand for these devices.
COMPETITIVE LANDSCAPE:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major drug-eluting stents market companies have also been provided. Some of the key players in the market include:
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global drug-eluting stents market in 2025?
2. What is the expected growth rate of the global drug-eluting stents market during 2026-2034?
3. What are the key factors driving the global drug-eluting stents market?
4. What has been the impact of COVID-19 on the global drug-eluting stents market?
5. What is the breakup of the global drug-eluting stents market based on the coating?
6. What is the breakup of the global drug-eluting stents market based on the stent platform?
7. What is the breakup of the global drug-eluting stents market based on application?
8. What is the breakup of the global drug-eluting stents market based on the end user?
9. What are the key regions in the global drug-eluting stents market?
10. Who are the key players/companies in the global drug-eluting stents market?
DRUG-ELUTING STENTS MARKET ANALYSIS:
- Major Market Drivers: The increasing prevalence of irregular heart rhythms, heart failure, and heart attack disease is stimulating the market.
- Key Market Trends: The widespread use of stents with polymer-free coatings is acting as a significant growth-inducing factor.
- Competitive Landscape: Some of the major market companies include Abbott, B. Braun SE, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology (Beijing) Co., Ltd, Medinol, Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc and Terumo Corporation, among many others.
- Geographical Trends: North America dominates the market owing to a robust healthcare system, rising incidence of coronary artery disease, and extensive use of innovative medical technologies.
- Challenges and Opportunities: The risk of late stent thrombosis is hampering the market. However, developing innovative stent technologies with greater biocompatibility and polymer-free coatings to increase patient safety is expected to fuel the market in the coming years.
Implementation of Next-Generation Drugs
The next generation of drug-eluting stents uses advanced medications, such as biolimus and zotarolimus, which have higher efficacy in preventing restenosis while reducing adverse effects, making these stents more useful for a wider variety of patients. For example, in May 2024, Abbott announced the launch of XIENCE Sierra Everolimus (drug) eluting coronary stent system in India. It is a CE-marked and one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. This is leading to the drug-eluting stents market growth.
Expanded Use in Peripheral Artery Disease
Drug-eluting stents are being increasingly utilized to treat peripheral arterial disease (PAD), moving beyond coronary applications. This trend reflects stents' growing use in treating blockages in arteries beyond the heart. In April 2024, Cook Medical received a contract to supply implantable devices to hospitals run by the U.S. Department of Defense (DoD). The company would provide its Zilver PTX drug-eluting peripheral stent, Zenith aortic endograft, and other implantable devices. This is expanding the drug-eluting stents market share.
Increasing Focus on Complex Lesions
Drug-eluting stents are in high demand for treating complicated coronary lesions such as bifurcation and multi-vessel disease. These advanced stents are designed to handle complex anatomical issues with more precision. In June 2024, Elixir Medical's DynamX Sirolimus-Eluting Coronary Bioadaptor System received Breakthrough Device Designation from the FDA. This bioadaptive implant aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease.
GLOBAL DRUG-ELUTING STENTS INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the drug-eluting stents market forecast at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on the coating, drug, stent platform, generation, application, and end user.
Breakup by Coating:
- Polymer Based Coating
- Polymer Free Coating
The report has provided a detailed breakup and analysis of the market based on the coating. This includes polymer based coating and polymer free coating. According to the report, polymer free coating represented the largest market segmentation.
Polymer free coating is intended to minimize inflammation and promote healing. These coatings improve medication delivery while eliminating the problems associated with polymers, resulting in better patient outcomes during cardiovascular treatments. This is elevating the drug-eluting stents market revenue.
Breakup by Drug:
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Others
The drug-eluting stents market overview highlights that sirolimus reduces cell development to avoid arterial narrowing, while paclitaxel inhibits cell division, resulting in better blood flow. Zotarolimus enhances healing while causing less adverse effects, and everolimus has been shown to reduce re-narrowing over time. Biolimus, a biodegradable alternative, promotes vascular recovery, providing a variety of therapy options in the market.
Breakup by Stent Platform:
- Stainless-steel
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
The report has provided a detailed breakup and analysis of the market based on the stent platform. This includes stainless-steel, cobalt-chromium, platinum-chromium, nitinol, and others. According to the report, cobalt-chromium represented the largest market segmentation.
Cobalt-chromium stents are well-known for their long-lasting, flexible, and biocompatible design. These stents have a sturdy construction but allow for thinner struts, which improves vessel support and reduces problems during cardiovascular treatments. This is elevating the drug-eluting stents market statistics.
Breakup by Generation:
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
The 1st generation drug-eluting stents used basic drug coatings to minimize restenosis. The 2nd generation increased safety by improving biocompatibility and using thinner struts. The 3rd generation focused on biodegradable polymers to improve healing, while the 4th generation uses polymer-free coatings to promote speedier recovery and reduce inflammation. Each generation represents advances in safety, efficacy, and patient outcomes.
Breakup by Application:
- Coronary Artery Disease
- Peripheral Artery Disease
The report has provided a detailed breakup and analysis of the market based on the application. This includes coronary artery disease and peripheral artery disease. According to the report, coronary artery disease represented the largest market segmentation.
The market largely focuses on coronary artery disease by releasing medications that prevent restenosis. These stents help to maintain artery patency, improve blood flow, and reduce the need for repeat treatments in patients with blocked or narrowed arteries.
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest market segmentation.
Hospitals are the primary end users in this market, as these devices are commonly utilized in cardiovascular surgeries to treat coronary artery disease. These stents are used in hospitals to improve patient outcomes, lower restenosis, and reduce the need for recurrent treatments. This represents one of the drug-eluting stents market recent opportunities.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America exhibits a clear dominance in the market. This can be attributed to the enhanced healthcare infrastructure, a high prevalence of cardiovascular illnesses, and the growing adoption of cutting-edge stent technology. The region's focus on reducing coronary artery disease promotes demand for these devices.
COMPETITIVE LANDSCAPE:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major drug-eluting stents market companies have also been provided. Some of the key players in the market include:
- Abbott
- B. Braun SE
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Lepu Medical Technology (Beijing) Co., Ltd
- Medinol
- Medtronic plc
- MicroPort Scientific Corporation
- Sino Medical Sciences Technology Inc
- Terumo Corporation
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global drug-eluting stents market in 2025?
2. What is the expected growth rate of the global drug-eluting stents market during 2026-2034?
3. What are the key factors driving the global drug-eluting stents market?
4. What has been the impact of COVID-19 on the global drug-eluting stents market?
5. What is the breakup of the global drug-eluting stents market based on the coating?
6. What is the breakup of the global drug-eluting stents market based on the stent platform?
7. What is the breakup of the global drug-eluting stents market based on application?
8. What is the breakup of the global drug-eluting stents market based on the end user?
9. What are the key regions in the global drug-eluting stents market?
10. Who are the key players/companies in the global drug-eluting stents market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRUG-ELUTING STENTS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COATING
6.1 Polymer Based Coating
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymer Free Coating
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DRUG
7.1 Sirolimus
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Paclitaxel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Zotarolimus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Everolimus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biolimus
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY STENT PLATFORM
8.1 Stainless-steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cobalt-Chromium
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Platinum-Chromium
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nitinol
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY GENERATION
9.1 1st Generation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 2nd Generation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 3rd Generation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 4th Generation
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY APPLICATION
10.1 Coronary Artery Disease
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Peripheral Artery Disease
10.2.1 Market Trends
10.2.2 Market Forecast
11 MARKET BREAKUP BY END USER
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 MARKET BREAKUP BY REGION
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT ANALYSIS
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 VALUE CHAIN ANALYSIS
15 PORTERS FIVE FORCES ANALYSIS
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 PRICE ANALYSIS
17 COMPETITIVE LANDSCAPE
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 B. Braun SE
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Biosensors International Group, Ltd.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Biotronik
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 SWOT Analysis
17.3.5 Boston Scientific Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Cook Medical
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 SWOT Analysis
17.3.7 Lepu Medical Technology (Beijing) Co., Ltd
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.8 Medinol
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Medtronic plc
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 MicroPort Scientific Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.11 Sino Medical Sciences Technology Inc
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Corporation
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRUG-ELUTING STENTS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COATING
6.1 Polymer Based Coating
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymer Free Coating
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DRUG
7.1 Sirolimus
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Paclitaxel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Zotarolimus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Everolimus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biolimus
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY STENT PLATFORM
8.1 Stainless-steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cobalt-Chromium
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Platinum-Chromium
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nitinol
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY GENERATION
9.1 1st Generation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 2nd Generation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 3rd Generation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 4th Generation
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY APPLICATION
10.1 Coronary Artery Disease
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Peripheral Artery Disease
10.2.1 Market Trends
10.2.2 Market Forecast
11 MARKET BREAKUP BY END USER
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 MARKET BREAKUP BY REGION
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT ANALYSIS
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 VALUE CHAIN ANALYSIS
15 PORTERS FIVE FORCES ANALYSIS
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 PRICE ANALYSIS
17 COMPETITIVE LANDSCAPE
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 B. Braun SE
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Biosensors International Group, Ltd.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Biotronik
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 SWOT Analysis
17.3.5 Boston Scientific Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Cook Medical
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 SWOT Analysis
17.3.7 Lepu Medical Technology (Beijing) Co., Ltd
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.8 Medinol
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Medtronic plc
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 MicroPort Scientific Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.11 Sino Medical Sciences Technology Inc
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Corporation
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million USD), 2026-2034
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million USD), 2026-2034
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million USD), 2026-2034
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million USD), 2026-2034
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players
Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million USD), 2026-2034
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million USD), 2026-2034
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million USD), 2026-2034
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million USD), 2026-2034
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players
LIST OF FIGURES
Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2025
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2025
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2025
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2025
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2025
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2025
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2025
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2025
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2025
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2025
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2025
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2025
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2025
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2025
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2025
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2025
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
